Age and factors associated with self-clean intermittent catheterization in patients with spina bifida

T J Atchley1, P P Dangle2, B D Hopson2

  • 1Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, USA.

Insights

Most children with spina bifida (SB) transition to self-clean intermittent catheterization (CIC) by age 10. Thoracic spinal lesions and Medicaid insurance are linked to a lower likelihood of self-CIC.

Area of Science:

  • Pediatric Urology
  • Neurogenic Bladder Management
  • Spina Bifida Research

Background:

  • Clean intermittent catheterization (CIC) is crucial for managing bladder dysfunction in children with spina bifida (SB).
  • Transitioning from caregiver-assisted to self-CIC is a key developmental milestone for independence.

Purpose of the Study:

  • To determine the typical age of transition from caregiver clean intermittent catheterization (CIC) to self-CIC in children with spina bifida (SB).
  • To identify factors associated with the ability to perform self-CIC in older children with SB.

Main Methods:

  • Retrospective, single-institution cohort study utilizing prospective data from the National Spina Bifida Patient Registry.
  • Analysis of transition age from caregiver-CIC to self-CIC for Aim 1.
  • Comparison of patients using self-CIC versus caregiver-CIC over age 10 for Aim 2, identifying associated variables.

Main Results:

  • Most patients (71.9%) transitioned to self-CIC by age 10, and 87.5% by age 14.
  • In patients aged 10 years and older using CIC, 287 out of 696 performed self-CIC.
  • Thoracic spinal lesions (OR 0.45) and Medicaid insurance (OR 0.24) were independently associated with a lower likelihood of self-CIC.

Conclusions:

  • While transition ages vary, the majority of children with SB achieve self-CIC by age 10.
  • Specific factors, including thoracic-level spinal lesions and reliance on Medicaid insurance, correlate with reduced odds of achieving self-CIC.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
236
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
324
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
703
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
262
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
253